2015
DOI: 10.4103/2394-6954.163081
|View full text |Cite
|
Sign up to set email alerts
|

A comparative study of labetalol and fentanyl on the sympathomimetic response to laryngoscopy and intubation in vascular surgeries

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
9
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(10 citation statements)
references
References 2 publications
0
9
0
Order By: Relevance
“…Moreover this drug targets 5-10 times more specific beta blockade 11,23 and prevent rebound hypertension and tachycardia. 20,10 Researchers used Labetalol and nitroprusside to induce hypotension in major surgeries and showed that nitroprusside significantly increased the heart rate but cardiac output remain unchanged with labetalol administration. 11 The arterial hypertension is due to increase in cardiac output rather than increase in systemic vascular resistance.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Moreover this drug targets 5-10 times more specific beta blockade 11,23 and prevent rebound hypertension and tachycardia. 20,10 Researchers used Labetalol and nitroprusside to induce hypotension in major surgeries and showed that nitroprusside significantly increased the heart rate but cardiac output remain unchanged with labetalol administration. 11 The arterial hypertension is due to increase in cardiac output rather than increase in systemic vascular resistance.…”
Section: Discussionmentioning
confidence: 99%
“…10 It lowers the blood pressure by decreasing systemic vascular resistance (alpha-1 blockade) whereas reflex tachycardia triggered by vasodilation is attenuated by simultaneous betablockade and cardiac output remains unchanged. 11 It has better safety profile and haemodynamic stability.…”
Section: Introductionmentioning
confidence: 99%
“…4 It is an antihypertensive drug available in oral and parenteral form.Labetalol shows selective antagonist activity over alpha-1 adrenergic receptors and nonselective blockade over beta-1 and beta-2 adrenergic receptors. 5 It shows antagonist activity over alpha and beta receptors in the ratio of alpha: beta = 1:7 for intravenous administration. 6 Thus the present study is undertaken to evaluate the efficacy between 0.15mg/kg and 0.25mg/kg of iv Labetalol in the suppression of haemodynamic response to extubation.…”
Section: Introductionmentioning
confidence: 99%
“…It lowers BP by decreasing systemic vascular resistance (a1-blockade), whereas reflex tachycardia triggered by vasodilatation is attenuated by simultaneous b-blockade. Cardiac output remains unchanged [11][12][13][14][15][16][17][18][19]. The aim of the present study was to compare the efficacy of two different doses of labetalol for controlling these hemodynamic responses to laryngoscopy and tracheal intubation under the same anesthetic techniques in hypertensive patients.…”
Section: Introductionmentioning
confidence: 99%